Source: Applied Microbiology and Biotechnology. Unidades: FCF, BIOTECNOLOGIA, IQ
Subjects: GRANULÓCITOS, ESCHERICHIA COLI
ABNT
EGUIA, Fara A. P; MASCARELLI, Daniele Enriquetto; CARVALHO, Enéas de; et al. Development of recombinant human granulocyte colony-stimulating factor (nartograstim) production process in Escherichia coli compatible with industrial scale and with no antibiotics in the culture medium. Applied Microbiology and Biotechnology, New York, v. 105, p. 169–183, 2021. Disponível em: < http://dx.doi.org/10.1007/s00253-020-11014-y > DOI: 10.1007/s00253-020-11014-y.APA
Eguia, F. A. P., Mascarelli, D. E., Carvalho, E. de, Rodríguez, G. R., Makiyama, E. N., Borelli, P., et al. (2021). Development of recombinant human granulocyte colony-stimulating factor (nartograstim) production process in Escherichia coli compatible with industrial scale and with no antibiotics in the culture medium. Applied Microbiology and Biotechnology, 105, 169–183. doi:10.1007/s00253-020-11014-yNLM
Eguia FAP, Mascarelli DE, Carvalho E de, Rodríguez GR, Makiyama EN, Borelli P, Lieberman C, Ho PL, Barazzone GC, Gonçalves VM. Development of recombinant human granulocyte colony-stimulating factor (nartograstim) production process in Escherichia coli compatible with industrial scale and with no antibiotics in the culture medium [Internet]. Applied Microbiology and Biotechnology. 2021 ; 105 169–183.Available from: http://dx.doi.org/10.1007/s00253-020-11014-yVancouver
Eguia FAP, Mascarelli DE, Carvalho E de, Rodríguez GR, Makiyama EN, Borelli P, Lieberman C, Ho PL, Barazzone GC, Gonçalves VM. Development of recombinant human granulocyte colony-stimulating factor (nartograstim) production process in Escherichia coli compatible with industrial scale and with no antibiotics in the culture medium [Internet]. Applied Microbiology and Biotechnology. 2021 ; 105 169–183.Available from: http://dx.doi.org/10.1007/s00253-020-11014-y